 |
 |
 |
|
- This new Irisin Elisa kit was formulated by the glycosylated human irisin derived from HEK293 cells and specific monoclonal antibody.
- The antibody was validated by the glycosylated human irisin derived from HEK293 cells and human serum samples on western blot.
- Irisin, a secreted myokine, is a circulating biomarker for metabolic syndrome.
The Most Cited Irisin Double Monoclonal Antibody Formulated ELISA Kit:
- Gonzalez-Gil AM, et al. Myokine-adipokine cross-talk: potential mechanisms for the association between plasma irisin and adipokines and cardiometabolic risk factors in Mexican children with obesity and the metabolic syndrome. Diabetol Metab Syndr. 2019 Aug 5;11:63. doi: 10.1186/s13098-019-0458-2. eCollection 2019
- Anna S. Huerta-Delgado, et al, "Serum Irisin Levels, Endothelial Dysfunction, and Inflammation in Pediatric Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome", Journal of Diabetes Research, vol. 2020, Article ID 1949415, 16 pages, 2020.
- Śliwicka E, et al. Effects of marathon race on selected myokines and sclerostin in middle-aged male amateur runners. Sci Rep. 2021 Feb 2;11(1):2813.
- Dr. Zheng-ping Zhang, et al. Serum irisin associated with breast cancer to spinal metastasis. Medicine (2018) 97:17 http://dx.doi.org/10.1097/MD.0000000000010524
- Zhang, Feng et al. “Serum Irisin as a Potential Biomarker for Cognitive Decline in Vascular Dementia.” Frontiers in neurology vol. 12 755046. 13 Sep. 2021, doi:10.3389/fneur.2021.755046
New Research:
- Eunhee Kim, et al. Irisin reduces amyloid-b by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling. Neuron 111, 3619–3633, November 15, 2023.
- Jo D, Song J. Irisin Acts via the PGC-1α and BDNF Pathway to Improve Depression-like Behavior. Clin Nutr Res. 2021 Oct 20;10(4):292-302. PMID: 34796134; PMCID: PMC8575642.
|
|
|
 |
|
 |
|